| Year |
Citation |
Score |
| 2023 |
Vila-Castelar C, Chen Y, Langella S, Lopera F, Zetterberg H, Hansson O, Dage JL, Janelidzde S, Su Y, Chen K, Pluim McDowell C, Martinez JE, Ramirez-Gomez L, Garcia G, Aguillon D, ... ... Protas HD, et al. Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37279390 DOI: 10.1002/alz.13314 |
0.318 |
|
| 2023 |
Malek-Ahmadi M, Su Y, Ghisays V, Luo J, Devadas V, Chen Y, Lee W, Protas H, Chen K, Zetterberg H, Blennow K, Caselli RJ, Reiman EM. Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults. Alzheimer's Research & Therapy. 15: 74. PMID 37038190 DOI: 10.1186/s13195-023-01221-w |
0.32 |
|
| 2023 |
Protas H, Ghisays V, Goradia DD, Bauer R, Devadas V, Chen K, Reiman EM, Su Y. Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer's disease continuum. Frontiers in Neuroscience. 17: 1089134. PMID 36937677 DOI: 10.3389/fnins.2023.1089134 |
0.372 |
|
| 2023 |
Smith GS, Protas H, Kuwabara H, Savonenko A, Nassery N, Gould NF, Kraut M, Avramopoulos D, Holt D, Dannals RF, Nandi A, Su Y, Reiman EM, Chen K. Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment. Neuroimage. Clinical. 37: 103322. PMID 36680976 DOI: 10.1016/j.nicl.2023.103322 |
0.327 |
|
| 2022 |
Reiman EM, Pruzin JJ, Rios-Romenets S, Brown C, Giraldo M, Acosta-Baena N, Tobon C, Hu N, Chen Y, Ghisays V, Enos J, Goradia DD, Lee W, Luo J, Malek-Ahmadi M, ... Protas H, et al. A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36373344 DOI: 10.1002/alz.12843 |
0.312 |
|
| 2022 |
Alosco ML, Su Y, Stein TD, Protas H, Cherry JD, Adler CH, Balcer LJ, Bernick C, Pulukuri SV, Abdolmohammadi B, Coleman MJ, Palmisano JN, Tripodis Y, Mez J, Rabinovici GD, et al. Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36152064 DOI: 10.1007/s00259-022-05963-x |
0.328 |
|
| 2022 |
Vila-Castelar C, Tariot PN, Sink KM, Clayton D, Langbaum JB, Thomas RG, Chen Y, Su Y, Chen K, Hu N, Giraldo-Chica M, Tobón C, Acosta-Baena N, Luna E, Londoño M, ... ... Protas HD, et al. Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35103388 DOI: 10.1002/alz.12552 |
0.331 |
|
| 2021 |
Ghisays V, Lopera F, Goradia DD, Protas HD, Malek-Ahmadi MH, Chen Y, Devadas V, Luo J, Lee W, Baena A, Bocanegra Y, Guzmán-Vélez E, Pardilla-Delgado E, Vila-Castelar C, Fox-Fuller JT, et al. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers. Neuroimage. Clinical. 31: 102749. PMID 34252876 DOI: 10.1016/j.nicl.2021.102749 |
0.353 |
|
| 2020 |
Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, Garcia G, Villegas A, Sepulveda-Falla D, Villada M, Arboleda-Velasquez JF, Guzmán-Vélez E, Vila-Castelar C, Gordon BA, Schultz SA, ... Protas HD, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study. The Lancet. Neurology. 19: 513-521. PMID 32470423 DOI: 10.1016/S1474-4422(20)30137-X |
0.31 |
|
| 2020 |
Rios-Romenets S, Lopera F, Sink KM, Hu N, Lian Q, Guthrie H, Smith J, Cho W, Mackey H, Langbaum JB, Thomas RG, Giraldo-Chica M, Tobon C, Acosta-Baena N, Muñoz C, ... ... Protas HD, et al. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32418361 DOI: 10.1002/Alz.12109 |
0.387 |
|
| 2019 |
Ghisays V, Goradia DD, Protas H, Bauer RJ, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR, Caselli RJ, Su Y, Chen K, Reiman EM. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31831374 DOI: 10.1016/J.Jalz.2019.08.195 |
0.399 |
|
| 2019 |
Quiroz YT, Tariot PN, Sink K, Clayton D, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Luna E, Londono M, Ospina P, Tirado V, Alvarez S, Chen K, ... ... Protas H, et al. F4-04-04: Association Between Cerebral Amyloidosis And Worse Cognitive Performance In Preclinical Autosomal Dominant Alzheimer'S Disease: Baseline Findings From The Api Colombia Autosomal Dominant Ad Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4728 |
0.467 |
|
| 2019 |
Su Y, Rios-Romenets S, Tariot PN, Sink K, Clayton D, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Navarro A, ... ... Protas H, et al. F4-04-03: Relationships Between Baseline Brain Imaging Biomarker Measurements And Age In The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4727 |
0.411 |
|
| 2019 |
Acosta-Baena N, Rios-Romenets S, Muñoz C, Bocanegra Y, Henao E, Giraldo M, Tobon C, Sink K, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Chen K, ... ... Protas H, et al. F4-04-02: Age-Related Changes In Baseline Cognitive Measures In Unimpaired Psen1 E280A Mutation Carriers And Non-Carriers In The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4726 |
0.413 |
|
| 2019 |
Tariot PN, Lopera F, Sink K, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Munoz C, Ospina P, Torado V, ... ... Protas H, et al. F4-04-01: Trial Design, Data Sharing Risk Mitigation, And Baseline Clinical And Cognitive Data From The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4725 |
0.39 |
|
| 2019 |
Ghisays V, Goradia DD, Protas H, Bauer R, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR, Caselli RJ, Su Y, Chen K, Reiman EM. O3-02-02: AMYLOID PET, TAU PET, AND MRI MEASUREMENTS IN COGNITIVELY UNIMPAIRED PERSONS WITH TWO, ONE, AND NO COPIES OF THE APOE4 ALLELE Alzheimer's & Dementia. 15: P878-P878. DOI: 10.1016/J.Jalz.2019.06.4631 |
0.454 |
|
| 2019 |
VanGilder PS, Luo J, Goradia DD, Ghisays V, Protas H, Thiyyagura P, Malek-Ahmadi M, Lee W, Chen Y, Devadas V, Reiman EM, Su Y. P4-308: AN ADAPTIVE SAMPLING FRAMEWORK FOR PARTIAL VOLUME CORRECTION OF β-AMYLOID PET Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3978 |
0.32 |
|
| 2019 |
Protas H, Pardilla-Delgado E, Lopera F, Johnson KA, Sperling RA, Artola A, Baena A, Bocanegra Y, Gatchel JR, Guzman-Velez E, Fuller J, Goradia DD, Thiyyagura P, VanGilder PS, Luo J, et al. Ic-P-058: Covarying Spatial Patterns Of Tau Deposition And Gray Matter Atrophy Unearthed By The Informed Multimodal Partial Least Squares (Mmpls) In Autosomal Dominant Alzheimer'S Disease: Findings From The Colbos Project Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2767 |
0.32 |
|
| 2019 |
Protas H, Goradia DD, Ghisays V, Luo J, VanGilder PS, Thiyyagura P, Malek-Ahmadi M, Lee W, Chen Y, Devadas V, Bauer R, Landau SM, Weiner MW, Jagust WJ, Chen K, et al. Ic-P-173: Individual-Based Network Analysis: A Novel Approach To Investigate The Pathological Spread Of Phf Tau Using Graph Theory In Clinical And Preclinical Stages Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1023 |
0.338 |
|
| 2018 |
Ghisays V, Protas H, Chen Y, DeMarco EL, Tariot PN, Langbaum JB, Quiroz YT, Lopera F, Reiman EM, Chen K. COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID-β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE KINDRED Alzheimers & Dementia. 14: 20. DOI: 10.1016/J.Jalz.2018.06.2074 |
0.377 |
|
| 2017 |
Norton DJ, Amariglio R, Protas H, Chen K, Aguirre-Acevedo DC, Pulsifer B, Castrillon G, Tirado V, Munoz C, Tariot P, Langbaum JB, Reiman EM, Lopera F, Sperling RA, Quiroz YT. Subjective memory complaints in preclinical autosomal dominant Alzheimer disease. Neurology. PMID 28878053 DOI: 10.1212/Wnl.0000000000004533 |
0.316 |
|
| 2017 |
Reiman EM, Kuang X, Luo J, Chen Y, Thiyyagura P, Bauer R, Lee W, Protas H, Goradia DD, Aisen PS, Johnson K, Langbaum JB, Sperling RA, Tariot P, Jagust WJ, et al. [IC-P-041]: SAMPLE SIZES FOR 24-MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS Alzheimer's & Dementia. 13: P36-P37. DOI: 10.1016/J.Jalz.2017.06.2313 |
0.365 |
|
| 2015 |
Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, et al. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. Jama Neurology. PMID 26121081 DOI: 10.1001/Jamaneurol.2015.1099 |
0.349 |
|
| 2015 |
Sabbagh MN, Chen K, Rogers J, Fleisher AS, Liebsack C, Bandy D, Belden C, Protas H, Thiyyagura P, Liu X, Roontiva A, Luo J, Jacobson S, Malek-Ahmadi M, Powell J, et al. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25849033 DOI: 10.1016/J.Jalz.2015.01.006 |
0.412 |
|
| 2015 |
Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, et al. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 560-6. PMID 25745091 DOI: 10.2967/Jnumed.114.149732 |
0.366 |
|
| 2015 |
Quiroz YT, Protas H, Chen K, Roontiva A, Thiyyagura P, Fagan AM, Shah A, Gutierrez M, Londono M, Giraldo M, Munoz C, Tirado V, Velilla L, Garcia G, Jaimes SY, et al. Relationships between baseline biomarkers and subsequent cognitive decline in cognitively unimpaired PSEN1 E280A mutation carriers from the colombian kindred with autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 888. DOI: 10.1016/J.Jalz.2015.08.098 |
0.38 |
|
| 2014 |
Dean DC, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muircheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, et al. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. Jama Neurology. 71: 11-22. PMID 24276092 DOI: 10.1001/Jamaneurol.2013.4544 |
0.375 |
|
| 2013 |
Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 10: 173-80. PMID 23702553 DOI: 10.1109/Tcbb.2012.141 |
0.384 |
|
| 2013 |
Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. Jama Neurology. 70: 320-5. PMID 23599929 DOI: 10.1001/2013.Jamaneurol.286 |
0.354 |
|
| 2013 |
Fleisher AS, Chen K, Liu X, Ayutyanont N, Roontiva A, Thiyyagura P, Protas H, Joshi AD, Sabbagh M, Sadowsky CH, Sperling RA, Clark CM, Mintun MA, Pontecorvo MJ, Coleman RE, et al. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiology of Aging. 34: 1-12. PMID 22633529 DOI: 10.1016/J.Neurobiolaging.2012.04.017 |
0.427 |
|
| 2013 |
Chen K, Stonnington C, Ayutyanont N, Reschke C, Thyyagura P, Protas H, Liu X, Roontiva A, Parks S, Bauer R, Lee W, Koeppe R, Jagust W, Foster N, Weiner M, et al. Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study Alzheimers & Dementia. 9: 844. DOI: 10.1016/J.Jalz.2013.08.007 |
0.435 |
|
| 2013 |
Bartell J, Burns C, Thiyyagura P, Li A, Parks S, Protas H, Lee W, Fleisher A, Kaszniak A, Chen K, Reiman E. Association between higher fasting serum glucose levels and the pattern of lower regional gray matter volumes in cognitively normal adults Alzheimers & Dementia. 9: 93. DOI: 10.1016/J.Jalz.2013.05.153 |
0.333 |
|
| 2013 |
Protas H, Chen K, Reschke C, Roontiva A, Liu X, Parks S, Lee W, Bauer R, Ayutyanont N, Thiyyagura P, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 68. DOI: 10.1016/J.Jalz.2013.05.109 |
0.421 |
|
| 2013 |
Roontiva A, Chen K, Ayutyanont N, Protas H, Liu X, Thiyyagura P, Lee W, Reschke C, Parks S, Bauer R, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 698. DOI: 10.1016/J.Jalz.2013.04.377 |
0.437 |
|
| 2012 |
Wilks MQ, Protas H, Wardak M, Kepe V, Small GW, Barrio JR, Huang SC. Automated VOI Analysis in FDDNP PET Using Structural Warping: Validation through Classification of Alzheimer's Disease Patients. International Journal of Alzheimer's Disease. 2012: 512069. PMID 22482071 DOI: 10.1155/2012/512069 |
0.649 |
|
| 2012 |
Protas HD, Kepe V, Hayashi KM, Klunder AD, Braskie MN, Ercoli L, Siddarth P, Bookheimer SY, Thompson PM, Small GW, Barrio JR, Huang SC. Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET. Neuroimage. 61: 749-60. PMID 22401755 DOI: 10.1016/J.Neuroimage.2012.02.056 |
0.603 |
|
| 2012 |
Langbaum JB, Chen K, Launer LJ, Fleisher AS, Lee W, Liu X, Protas HD, Reeder SA, Bandy D, Yu M, Caselli RJ, Reiman EM. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiology of Aging. 33: 827.e11-9. PMID 21821316 DOI: 10.1016/J.Neurobiolaging.2011.06.020 |
0.42 |
|
| 2012 |
Protas H, Chen K, Reschke C, Roontiva A, Lee W, Nishimura M, Ayutyanont N, Liu X, Thiyyagura P, Parks S, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares Alzheimers & Dementia. 8: 20. DOI: 10.1016/J.Jalz.2012.05.056 |
0.441 |
|
| 2010 |
Protas HD, Huang SC, Kepe V, Hayashi K, Klunder A, Braskie MN, Ercoli L, Bookheimer S, Thompson PM, Small GW, Barrio JR. FDDNP binding using MR derived cortical surface maps. Neuroimage. 49: 240-8. PMID 19703569 DOI: 10.1016/J.Neuroimage.2009.08.035 |
0.587 |
|
| 2010 |
Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, et al. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiology of Aging. 31: 1669-78. PMID 19004525 DOI: 10.1016/J.Neurobiolaging.2008.09.012 |
0.507 |
|
| 2007 |
Small GW, Protas HD, Huang S, Kepe V, Siddarth P, Hayashi K, Klunder A, Braskie M, Ercoli LM, Bookheimer SY, Thompson PM, Barrio JR. O2-02-05: FDDNP-PET binding values from cortical hemispheric surface maps correlate with MMSE scores Alzheimer's & Dementia. 3: S186-S186. DOI: 10.1016/J.Jalz.2007.04.039 |
0.345 |
|
| 2006 |
Ghisays V, Goradia DD, Protas H, Bauer R, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR, Caselli RJ, Chen K, Reiman EM. P4-318: PET MEASUREMENTS OF PHF TAU BURDEN IN COGNITIVELY UNIMPAIRED PERSONS WITH TWO, ONE AND NO COPIES OF THE APOE4 ALLELE Alzheimer's & Dementia. 14: P1580-P1580. DOI: 10.1016/J.Jalz.2018.07.141 |
0.436 |
|
| 2006 |
Protas H, Ghisays V, Luo J, DeMarco EL, Thiyyagura P, Devadas V, Bauer R, Landau SM, Weiner M, Jagust WJ, Reiman EM, Chen K. IC-P-106: FLORTAUCIPIR PAIRED HELICAL FILAMENT TAU BURDEN AND CORRELATION WITH COGNITIVE DECLINE IN MCI PATIENTS WITHOUT Aβ Alzheimer's & Dementia. 14: P91-P92. DOI: 10.1016/J.Jalz.2018.06.2172 |
0.377 |
|
| 2005 |
Leow A, Yu CL, Lee SJ, Huang SC, Protas H, Nicolson R, Hayashi KM, Toga AW, Thompson PM. Brain structural mapping using a novel hybrid implicit/explicit framework based on the level-set method. Neuroimage. 24: 910-27. PMID 15652325 DOI: 10.1016/J.Neuroimage.2004.09.022 |
0.573 |
|
| 2005 |
Protas HD, Thompson PM, Hayashi KM, Yu CL, Bergsneider M, Huang SC. Regional quantitative analysis of cortical surface maps of FDG PET images Ieee Nuclear Science Symposium Conference Record. 3: 1814-1817. DOI: 10.1109/NSSMIC.2005.1596673 |
0.329 |
|
| Show low-probability matches. |